Evidence map›Paper›PMID 40814641›Full record

ArticleKidney international reports2025

Characterizing the ADPKD-

Ahmad Ghanem, Fadi George Munairdjy Debeh, Abdul Hamid Borghol, Nikola Zagorec, Amanda L Tapia, Byron Smith, Stefan Paul, Abdul Basit, Bassel AlKhatib, Nay Nader and 11 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Kidney international reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Ahmad GhanemDivision of Nephrology and Hypertension, Mayo Clinic, Jacksonville, Florida, USA.
Fadi George Munairdjy DebehDivision of Nephrology and Hypertension, Mayo Clinic, Jacksonville, Florida, USA.
Abdul Hamid BorgholDivision of Nephrology and Hypertension, Mayo Clinic, Jacksonville, Florida, USA.
Nikola ZagorecUniversity Brest, Inserm, UMR 1078, GGB, CHU Brest, Centre de Références Maladies Rénales Héréditaires de L'enfant et de L'adulte MARHEA, F-29200 Brest, France.
Amanda L TapiaDivision of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
Byron SmithDivision of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
Stefan PaulDivision of Nephrology and Hypertension, Mayo Clinic, Jacksonville, Florida, USA.
Abdul BasitDivision of Nephrology and Hypertension, Mayo Clinic, Jacksonville, Florida, USA.
Bassel AlKhatibDivision of Nephrology and Hypertension, Mayo Clinic, Jacksonville, Florida, USA.
Nay NaderDivision of Nephrology and Hypertension, Mayo Clinic, Jacksonville, Florida, USA.
Marie Therese Bou AntounDivision of Nephrology and Hypertension, Mayo Clinic, Jacksonville, Florida, USA.
Adriana V GregoryDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
Hana YangDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
Rachel S SchauerDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
Neera K DahlDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
Christian HannaDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
Vicente E TorresDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
Timothy L KlineDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
Peter C HarrisDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
Emilie Cornec-Le GallUniversity Brest, Inserm, UMR 1078, GGB, CHU Brest, Centre de Références Maladies Rénales Héréditaires de L'enfant et de L'adulte MARHEA, F-29200 Brest, France.
Fouad T ChebibDivision of Nephrology and Hypertension, Mayo Clinic, Jacksonville, Florida, USA.

Funding

Transgenic and Knockout Models of ADPKDR01DK059597 · NIDDK · MAYO CLINIC ROCHESTER · PI Peter C. Harris · 2002 to 2026
$9.5M
NIDDK NIH HHS R01 DK059597
6 · The paper itself

Abstract

Introduction: ADPKD Methods: This retrospective cohort study included patients with disease-causing variants in Results: Patients with ADPKD- Conclusion: We provide a detailed characterization of the ADPKD

Indexed as

ADPKDatypicalCKDcystcyst segmentationIFT140imaging biomarkersPKDpolycystic kidney diseasepredictive modeltotal kidney volume

Identifiers

PMID40814641
PMCPMC12348249

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.